VERNIERI, CLAUDIO

VERNIERI, CLAUDIO  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 100 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer 2025 Berton Giachetti, Pier Paolo MariaMarra, AntonioCorti, ChiaraBoldrini, LauraSposetti, CaterinaCarnevale Schianca, AmbraZagami, PaolaTrapani, DarioMalagutti, BiancaVernieri, ClaudioCurigliano, GiuseppeCriscitiello, Carmen + Article (author) -
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study 2024 Curigliano, GiuseppeVernieri, ClaudioSposetti, Caterina + Article (author) -
Management of patients with locally recurrent rectal cancer with a previous history of distant metastases: retrospective cohort study 2024 Vigorito, RaffaellaSabella, GiovannaPatti, FilippoRandon, GiovanniPietrantonio, FilippoVernieri, Claudio + Article (author) -
Cyclic Fasting-Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia 2024 Vernieri, ClaudioLazzeri, SamuelShmahala, AnastasiyaCasola, Stefanode Braud, Filippo + Article (author) -
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study 2024 Vernieri, ClaudioCurigliano, Giuseppe + Article (author) -
Immune and Gene-expression Profiling in Estrogen Receptor Low and Negative Early Breast Cancer 2024 Vernieri, ClaudioCriscitiello, CarmenVingiani, AndreaPescia, CarloFusco, NicolaPruneri, GiancarloCurigliano, Giuseppe + Article (author) -
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology 2024 Giugliano, FVernieri, C + Article (author) -
Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trial 2024 Provenzano, LeonardoNasca, VincenzoSposetti, CaterinaFranza, AndreaVingiani, AndreaPruneri, Giancarlode Braud, FilippoVernieri, Claudio + Article (author) -
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers 2024 Curigliano, GVernieri, C + Article (author) -
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study 2024 Vernieri, Claudio + Article (author) -
International consensus on fasting terminology 2024 Vernieri, Claudio + Article (author) -
Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence 2024 Vernieri, ClaudioLigorio, Francesca + Article (author) -
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care 2023 Vingiani, AndreaLorenzini, DanieleVernieri, ClaudioBusico, AdeleDe Braud, FilippoPruneri, Giancarlo + Article (author) -
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2 2023 Pusceddu, SaraNichetti, FedericoBusico, AdeleLeporati, RitaOldani, SimonePircher, Chiara CarlottaCoppa, JorgelinaMaccauro, MarcoNiger, MonicaPietrantonio, FilippoMariani, LuigiMazzaferro, VincenzoDi Liberti, Giorgiade Braud, FilippoVernieri, Claudio + Article (author) -
Real-world progression-free survival 2 with CDK4/6 inhibitors plus endocrine therapy and subsequent line: Results from the multicenter SISTER study 2023 Corti, C.Sposetti, C.Boldrini, L.Vernieri, C.Curigliano, G.Criscitiello, C. + Article (author) -
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis 2023 Provenzano, LeonardoLobefaro, RiccardoLigorio, FrancescaZattarin, EmmaZambelli, LucaSposetti, CaterinaMontelatici, GiuliaDel Vecchio, MartaLauria Pantano, Claudiade Braud, FilippoVernieri, Claudio + Article (author) -
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer 2023 Viale, GiuliaGiuliano, MarioCurigliano, GiuseppeVernieri, ClaudioRognone, AlessiaSica, LorenzoCriscitiello, Carmen + Article (author) -
Fasting-mimicking diet: a metabolic approach for the treatment of breast cancer 2023 Ligorio, FrancescaProvenzano, LeonardoVernieri, Claudio Article (author) -
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors 2023 Zattarin, EmmaMariani, LuigiLeporati, RitaProvenzano, LeonardoLigorio, FrancescaLobefaro, RiccardoVingiani, AndreaNichetti, FedericoBernocchi, OttaviaMarra, AntonioZagami, PaolaSposetti, CaterinaLosurdo, AgneseGenerali, DanieleCurigliano, GiuseppePruneri, Giancarlode Braud, FilippoVernieri, Claudio + Article (author) -
Central Obesity, Body Mass Index, Metabolic Syndrome and Mortality in Mediterranean Breast Cancer Patients 2023 C. VernieriC. La Vecchia + Article (author) -